Safety

Bioshield plan comes under questioning in Congress

Emergency Management Alert, April 10, 2003

Two weeks after approval from a Senate committee, President Bush's "Bioshield" proposal for encouraging commercial research and production of bioterror vaccine faced bipartisan questions on April 4 from the House Government Reform Committee, according to CongressDaily.

Lawmakers questioned aspects of the program, such as the loosening of government procurement rules and the waiver of Food and Drug Administration (FDA) approval for certain drugs in an emergency. Committee member Henry Waxman, D-CA, also noted that the plan limited the government's ability to sue companies that abuse contracts, adding that the FDA waiver could lead to the widespread distribution of unapproved drugs.

Officials from the Health and Human Services Department agreed to work with the committee to address any concerns. On the Senate side, the Bioshield proposal could reach the Senate floor the week of April 7.

    Hospital Safety Center
  • Hospital Safety Center

    Improve compliance with hospital safety standards from The Joint Commission, OSHA, and other regulators with this...

  • Healthcare Life Safety Compliance

    Learn Life Safety Code tips and interpretations for healthcare facilities with this in-depth monthly resource.

  • Hospital Safety Connection

    Stay on top of hospital safety requirements and best practices with our free, fast-paced weekly update.

  • Administering Your OSHA Program

    This course will help an employee new to the role of OSHA safety officer. It gives an overview of OSHA requirements and...

  • Medical OSHA Manual Combo

    Get into compliance with Quality America's OSHA Safety Program Manual and stay in compliance with OSHA Watch Newsletter...

Most Popular

Related Articles